4-hydroxycyclophosphamide has been researched along with Acute Myelogenous Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarkson, BD; Gasparetto, C; Gulati, SC; Lemoli, RM; Moore, MA; Scheinberg, DA | 1 |
1 trial(s) available for 4-hydroxycyclophosphamide and Acute Myelogenous Leukemia
Article | Year |
---|---|
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Topics: Adult; Aged; Antibodies, Monoclonal; Bone Marrow Transplantation; Cell Line; Colony-Forming Units Assay; Cyclophosphamide; Cytotoxicity, Immunologic; Etoposide; Female; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Interleukin-1; Interleukin-3; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation, Autologous | 1991 |